Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation)usually mild to moderate and often diminishing over time Injection site reactions Headache Fatigue More serious but rare adverse effects have been identified, including: Pancreatitis patients should seek urgent medical advice for severe, persistent abdominal pain (with or without vomiting) Gallbladder disease symptoms include upper right abdominal pain and jaundice Diabetic retinopathy complications particularly with rapid HbA1c reduction in patients with pre-existing retinopathy Dehydration and acute kidney injury from persistent gastrointestinal symptoms When combined with sulfonylureas or insulin, GLP-1 receptor agonists increase the risk of hypoglycaemia
Baseline labs often include fasting glucose, A1C, lipid panels, and sometimes inflammatory markers
These arent mass-produced by pharmaceutical manufacturers and are not FDA-approved in the same way brand-name medications are
Ovarian tissue cryopreservation in children and adolescents
No production clutter No fillers, binders or machine flow agents are added by Crown Supplements
Kwon R, Chang Y, Kim Y, et al